KEY FINANCIAL INFORMATION

(Thousand Pesos at December 31 of each year*)

 

GSanborns 2015 2016 2017 Var%  
Total Sales 44,413,058 47,593,847 49,768,427 4.6%  
Retail Sales 41,482,002 44,411,275 46,158,968 3.9%  
Credit Income 2,931,056 3,182,572 3,609,459 13.4%  
Gross Profit 17,475,621 18,922,460 19,723,561 4.2%  
Operating Income 4,907,774 6,620,253 5,158,410 -22.1%  
Operating Margin 11.1% 13.9% 10.4% -3.5 pp
EBITDA 5,707,369 6,474,141 6,332,165 -2.2%  
EBITDA Margin 12.9% 13.6% 12.7% -0.9 pp
Controlling Participation in Net Income 3,090,017 4,466,305 3,957,856 -11.4%  
Net Margin 7.0% 9.4% 8.0% -1.4 pp
           
Total Assets 41,364,031 45,185,043 47,887,914 6.0%  
Total Liabilities 11,968,900 14,233,518 15,368,164 8.0%  
Consolidated Shareholders´ Equity 29,395,131 30,951,525 32,519,750 5.1%  
Capital Expenditures (CapEx) 2,255,645 2,904,956 1,583,697 -45.5%  
Total Debt 0 0 0 N/A  
Net Debt -4,855,573 -1,714,356 -1,924,601 12.3%  
           
Total Sales Area (Sqm) 1,114,916 1,186,230 1,207,060 6.4%  
Credit Portfolio 10,824,130 12,008,846 12,894,303 10.9%  
% Non-Performing Loans 3.2% 2.8% 4.3% 1.5 pp
Credit Cards Issued 3,461,926 3,672,865 3,941,514 6.1%  
           
Net Debt/EBITDA -0.85 -0.26 -0.30 14.8%  
CapEx/Sales 5.1% 6.1% 3.2% -2.9 pp
Compounded Average Shares Outstanding
(thousand)
2,320,677 2,304,320 2,296,548 -0.3%  
Earnings Per Share** 1.33 1.94 1.72 -11.1%  
Closing Year Stock Price*** 26.36 21.69 19.60 -9.6%  

* Except outstanding shares, earnings per share and number of credit cards.
** Controlling Participation in Net Income divided by the compounded average number of outstanding shares.
*** Started quoting in the MSE on February 8th, 2013.
pp: Variation in percentage points.
EBITDA: Income before income taxes plus depreciation and amortization, interest expense, impairment of machinery and equipment and exploration expenses, and effect on valuation of derivative financial instruments, less interest income, net foreign exchange gain, surplus from appraisals of shopping centers and equity in earnings of associated companies and joint ventures. Review EBITDA conciliation in Note 26 of the Financial Statements.